Canada Starts Review of Medicago’s Rolling Submission for COVID-19 Vaccine

April 27, 2021
Medicago, a Canadian subsidiary of Mitsubishi Tanabe Pharma, said on April 23 that Health Canada has started the review of the company’s rolling submission for its plant-derived adjuvanted COVID-19 vaccine candidate. Health Canada accepted the first portion of the rolling...read more